Brought to you by 
Genzyme to acquire OR supplier Deknatel for $250mm
13 Jul 1999
Executive Summary
To establish a marketing presence for its recently-approved post-surgical adhesion products, Genzyme will acquire surgical products supplier Deknatel Snowden Pencer for $250mm in cash.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com